Clinical Trial Update: Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan

View source ↗

Summary

Real-world outcomes of adalimumab in rheumatoid arthritis patients in Taiwan have been reported following completion of the clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2019-03-14